The appropriate basal function of Nrf2 and Keap1 is essential for oncogenic process prevention in the colon; however, Nrf2 overactivation, resulting from Nrf2-induced inflammation and resistance to chemotherapy, increases colon cancer risk [36]. This evidence concerns the gene NFE2L2 and malignant colon neoplasm.